IP Library › Granted Patent US 12,712,079
Granted Patent B2
US 12,712,079 · App. 18/500,604 · Granted Aug 18, 2026

Diagnostic systems and methods for animal patients with global data center and local autonomous cell

Inventors: Alexander P. Lazarev (Lake Forest, CA); Delvin Tai Wai Yuk (Atherton, CA); Pavel Lazarev (Box Elder, SD)
Assignee: Aura Diagnostics, Inc.
G16H50/20G16H50/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,712,079
App. No.
18/500,604
Filed
Nov 2, 2023
Granted
Aug 18, 2026
Kind
B2
Art Unit
3682
USPC
705/2
Abstract

The techniques described herein relate to systems and methods for diagnosing diseases in animal patients. In some cases, a method includes providing a set of global data to a global data center and processing the set of global data and categorizing it into data clusters, where each data cluster corresponds to a diagnostic indicator for assessment of a physiological or pathological condition. The method can further include measuring data of a local patient using measurement equipment of a local autonomous cell and communicating the local measurement data from the local autonomous cell to the global data center. The local measurement data can be processed, and the processed local measurement data can be compared with the data clusters to determine a local diagnostic indicator for the local patient. The local diagnostic indicator can then be communicated from the global data center to the local autonomous cell.

Claims (40)

1 . A method for diagnosing diseases in animal patients comprising:

providing a set of global data to a global data center, including data from one or more tissue diffractometers;

training, by one or more processors, a machine learning algorithm, based on the set of global data, to generate a plurality of diagnostic indicators for assessment of physiological or pathological conditions;

categorizing, by the one or more processors and the trained machine learning algorithm, the set of global data into data clusters, where each data cluster is associated with a diagnostic indicator of the plurality of diagnostic indicators for a diagnosis of a disease;

measuring a local measurement data of a biological tissue of a patient using measurement equipment of a local autonomous cell, wherein the patient is an animal, the measurement equipment is a diffractometer configured to perform X-ray scattering measurements of a molecular structure of the biological tissue to collect diffraction pattern data related to ordering of the biological tissue, and the diffraction pattern data comprises a scattering pattern;

communicating the local measurement data and patient data from the local autonomous cell to the global data center;

pre-processing the local measurement data, by the one or more processors and the trained machine learning algorithm, to denoise, segment, mask, and/or enhance edges and/or features of the local measurement data;

processing the pre-processed local measurement data and comparing the processed local measurement data with the data clusters to determine one of the diagnostic indicators, wherein processing and comparing are performed by the one or more processors and the trained machine learning algorithm by operating upon the diffraction pattern data, and the diagnostic indicator includes a diagnosis that the patient has a disease; and

communicating the diagnostic indicator from the global data center to the local autonomous cell to be displayed on a user interface of a computer screen.

2 . The method of claim 1 , wherein the measuring the local measurement data comprises measuring a sample comprising α-keratin or collagen.

3 . The method of claim 1 , wherein the measuring the local measurement data comprises in vivo or in vitro measurement of a sample comprising hair, nail, skin, wool, horns, hooves, or tissue of an internal organ.

4 . The method of claim 1 , wherein the set of global data is provided from a certain geographical region or nation.

5 . The method of claim 1 , wherein the one or more processors is in a cloud, and uses cloud computing to process data using a distributed network of computers.

6 . The method of claim 1 , wherein the global data center comprises the one or more processors.

7 . The method of claim 1 , further comprising an analytical center in communication with the global data center, wherein the analytical center comprises the one or more processors.

8 . The method of claim 1 , further comprising:

measuring a plurality of local measurement data of a plurality of patients using a plurality of measurement equipment of a plurality of local autonomous cells, wherein:

the local measurement data is one of the plurality of local measurement data;

the patient is one of the plurality of patients;

the measurement equipment is one of the plurality of measurement equipment;

the local autonomous cell is one of the plurality of local autonomous cells; and

a plurality of patient data is associated with the plurality of patients;

communicating the plurality of local measurement data and the plurality of patient data from the plurality of local autonomous cells to the global data center;

processing the plurality of local measurement data using the one or more processors, wherein the processing is performed by the machine learning algorithm that determines a plurality of diagnostic indicators for the plurality of patients; and

communicating the plurality of diagnostic indicators from the global data center to the plurality of local autonomous cells.

9 . The method of claim 8 , wherein local autonomous cells of the plurality of local autonomous cells are in different geographic locations.

10 . The method of claim 1 , further comprising providing a biological tissue sample from the patient to the local autonomous cell to be measured using the measurement equipment.

11 . The method of claim 10 , wherein the biological tissue sample comprises one or more of a surgical sample, a resection sample, a pathology sample, or a biopsy sample.

12 . The method of claim 10 , wherein the biological tissue sample comprises one or more of hair, nail, skin, or tissue of an internal organ.

13 . The method of claim 10 , wherein the providing a biological tissue sample from the patient to the local autonomous cell comprises the patient or a veterinary services provider of the patient using a second user interface to input the patient data and sending the biological tissue sample by mail.

14 . The method of claim 1 , wherein the communicating the local measurement data and the patient data from the local autonomous cell to the global data center is done by an owner of the patient or a veterinary services provider of the patient using a second user interface.

15 . The method of claim 1 , further comprising communicating the diagnostic indicator from the local autonomous cell to an owner of the patient or a veterinary services provider of the patient using the user interface.

16 . The method of claim 1 , further comprising encrypting the local measurement data and the patient data using a data encryption device coupled to the measurement equipment, wherein the communicating the local measurement data and the patient data from the local autonomous cell to the global data center comprises communicating the encrypted local measurement data and encrypted the patient data from the local autonomous cell to the global data center.

17 . The method of claim 1 , wherein the global data center further comprises a global database stored on a central server or in a cloud, wherein the global database comprises the set of global data.

18 . The method of claim 1 , further comprising depersonalizing the local measurement data, the patient data, or any combination thereof before communicating the local measurement data and the patient data from the local autonomous cell to the global data center, wherein the communicating the local measurement data and the patient data from the local autonomous cell to the global data center comprises communicating the depersonalized local measurement data and the depersonalized patient data from the local autonomous cell to the global data center.

19 . The method of claim 18 , wherein a key for mapping the depersonalized local measurement data, the patient data, or any combination thereof is stored in a local institutional database or in an individual personal file of the patient.

20 . The method of claim 1 , wherein the patient data comprises descriptions or data related to symptoms of the patient comprising one or more of sleep disorders, insomnia, sudden awakenings, somnambulism, apnea, disorders of cerebral circulation, electroencephalogram (EEG) data, sudden convulsions and fainting, headaches and dizziness, and traumatic brain injuries.

21 . The method of claim 1 , wherein the diagnostic indicator relates to one of more of breast cancer, brain cancer, bone cancer, lung cancer, cervical cancer, bladder cancer, head cancer, neck cancer, kidney cancer, intestinal cancer, liver cancer, ovarian cancer, pancreatic cancer, prostate cancer, skin cancer, throat cancer, oral cancer, vaginal cancer, sinus tachycardia of a heart, atrial extra-systoles, ventricular extra-systoles, acute myocardial infarction, heart valve defect, cardiomyopathy, ventricular hypertrophy, heart failure, arrhythmia, atrial fibrillation of the heart, pericarditis, bradycardia of the heart, myocarditis, ischemic stroke, neurological stroke, cognitive decline, glioblastoma, extra-cerebral tumors, bacterial endocarditis (inflammation of an inner lining of the heart), and meningococcal meningitis (inflammation of the membranes of a brain and spinal cord).

22 . The method of claim 1 , wherein the communicating the local measurement data and the patient data from the local autonomous cell to the global data center is done by mail, airmail, courier mail or e-mail.

23 . The method of claim 1 , wherein the communicating the local measurement data and the patient data from the local autonomous cell to the global data center or the communicating the diagnostic indicator from the global data center to the local autonomous cell occurs about once per day, or about once per week, or about once per month on average.

Assignments (2)
CHANGE OF NAME Recorded May 12, 2026
From: ARION DIAGNOSTICS, INC.
To: AURA DIAGNOSTICS, INC.
Reel/Frame 075564/0494 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2023
From: LAZAREV, ALEXANDER P.; YUK, DELVIN TAI WAI; LAZAREV, PAVEL
To: ARION DIAGNOSTICS, INC.
Reel/Frame 065915/0948 →
Continuity (1)
Related Publication 20250149166A1 · May 8, 2025
References Cited (134)
US 5479927A · Shmulewitz · 1996 [cited by applicant]
US 5717733A · Kurbatov et al. · 1998 [cited by applicant]
US 5849595A · Alfano et al. · 1998 [cited by applicant]
US 6175117B1 · Komardin et al. · 2001 [cited by applicant]
US 6483891B1 · Lazarev et al. · 2002 [cited by applicant]
US 8126228B2 · Fueyo et al. · 2012 [cited by applicant]
US 9529974B2 · Li · 2016 [cited by examiner]
US 10534895B2 · Ambrose et al. · 2020 [cited by applicant]
US 11522703B1 · Jain et al. · 2022 [cited by applicant]
US 11901056B2 · Neumann · 2024 [cited by applicant]
US 12300370B2 · Kohn · 2025 [cited by applicant]
US 20030014418A1 · Adler et al. · 2003 [cited by applicant]
US 20030135096A1 · Dodds · 2003 [cited by examiner]
US 20040258202A1 · Wernick et al. · 2004 [cited by applicant]
US 20060015265A1 · Raich · 2006 [cited by applicant]
US 20070032832A1 · Feher · 2007 [cited by applicant]
US 20080147554A1 · Stevens et al. · 2008 [cited by applicant]
US 20130208966A1 · Zhao et al. · 2013 [cited by applicant]
US 20150269323A1 · Ginsburg · 2015 [cited by applicant]
US 20150369759A1 · Mazor et al. · 2015 [cited by applicant]
US 20160203263A1 · Maier et al. · 2016 [cited by applicant]
US 20160235372A1 · Schneider et al. · 2016 [cited by applicant]
US 20170362585A1 · Wang et al. · 2017 [cited by applicant]
US 20180038845A1 · Zimmermann et al. · 2018 [cited by applicant]
US 20180122499A1 · Austin et al. · 2018 [cited by applicant]
US 20190046039A1 · Ramesh et al. · 2019 [cited by applicant]
US 20190113451A1 · Weissleder et al. · 2019 [cited by applicant]
US 20190271044A1 · Stephan et al. · 2019 [cited by applicant]
US 20200098476A1 · Loscutoff et al. · 2020 [cited by applicant]
US 20200160980A1 · Lyman · 2020 [cited by examiner]
US 20200242760A1 · Holmes · 2020 [cited by applicant]
US 20220008027A1 · Lazarev et al. · 2022 [cited by applicant]
US 20220013227A1 · Lazarev et al. · 2022 [cited by applicant]
US 20220013233A1 · Lazarev et al. · 2022 [cited by applicant]
US 20220399126A1 · John · 2022 [cited by examiner]
US 20220415505A1 · Lazarev et al. · 2022 [cited by applicant]
US 20230113064A1 · Yuk et al. · 2023 [cited by applicant]
US 20230240635A1 · Lazarev et al. · 2023 [cited by applicant]
US 20230270396A1 · Lazarev et al. · 2023 [cited by applicant]
US 20230341340A1 · Lazarev et al. · 2023 [cited by applicant]
US 20240000412A1 · Lazarev et al. · 2024 [cited by applicant]
US 20240016462A1 · Lazarev et al. · 2024 [cited by applicant]
US 20240161893A1 · Lazarev et al. · 2024 [cited by applicant]
US 20250149170A1 · Lazarev · 2025 [cited by examiner]
CN 105849744A · 2016 [cited by applicant]
CN 107106998B · 2018 [cited by examiner]
CN 110400617A · 2019 [cited by applicant]
CN 112951416A · 2021 [cited by examiner]
CN 113012823A · 2021 [cited by applicant]
CN 113533399A · 2021 [cited by examiner]
CN 114599407A · 2022 [cited by examiner]
CN 115769069A · 2023 [cited by examiner]
JP H0933700A · 1997 [cited by applicant]
KR 20180076702A · 2018 [cited by applicant]
WO WO2004071295A1 · 2004 [cited by examiner]
WO WO2005112752A1 · 2005 [cited by examiner]
WO WO2012048000A2 · 2012 [cited by examiner]
WO WO2013131156A1 · 2013 [cited by examiner]
WO WO2018081884A1 · 2018 [cited by examiner]
WO 2019157214A2 · 2019 [cited by applicant]
WO 2021222866A1 · 2021 [cited by applicant]
WO 2021257451A1 · 2021 [cited by applicant]
WO 2021257457A1 · 2021 [cited by applicant]
Franke D, Jeffries C, Svergun D. “Machine Learning Methods for X-Ray Scattering Data Analysis from Biomacromolecular Solutions,” Biophysical Journal, vol. 114, Issue 11, P2485-2492, Jun. 5, 2018. (Year: 2018). [cited by examiner]
Ahmadian et al., “Monitoring of drug resistance towards reducing the toxicity of pharmaceutical compounds: Past, present and future”, Journal of Pharmaceutical and Biomedical Analysis, Mar. 19, 2020, 12 pgs. [cited by applicant]
Alfenaar, et al., “Therapeutic Drug Monitoring in Non Tuberculosis Mycobacteria Infections”, Clinical Pharmacokinetics, Mar. 10, 2021, 15 pgs. [cited by applicant]
Arboleda et al., Assessing lesion malignancy by scanning small-angle X-ray scattering of breast tissue with microcalcifications, Phys Med Biol. Aug. 7, 2019;64(15):155010, pp. 1-9. [cited by applicant]
Buclin et al., “The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib”, Frontiers in Pharmacology, vol. 11, Article 177, Mar. 3, 2020, 10 pgs. [cited by applicant]
Chapman et al., Diffraction enhanced x-ray imaging, Phys. Med. Biol. 42, Nov. 1997, pp. 2015-2025. [cited by applicant]
Conceicao et al., Analysis of breast cancer by small angle X-ray scattering (SAXS), Analyst, Apr. 2009 134(6):1077-82. [cited by applicant]
European Search Report dated May 24, 2024 for European Patent Office Patent Application No. 21826535.3. [cited by applicant]
Fagundes et al., “Structural characterization of canine mammary tissue by x-ray diffraction”, Radiation Physics and Chemistry, vol. 155, pp. 22-25. (Year: 2019). [cited by applicant]
Ghammraoui et al., “Maximum-likelihood estimation of scatter components algorithm for x-ray coherent scatter computed tomography of the breast”, Physics in Medicine & Biology, vol. 61, pp. 3164-3179. (Year: 2016). [cited by applicant]
Ghiculescu, “Therapeutic drug monitoring: which drugs, why, when and how to do it”, Australian Prescriber, vol. 31, No. 2, Apr. 2008, pp. 42-44. [cited by applicant]
Graewet et al., “Impact and progress in small and wide angle X-ray scattering (SAXS and WAXS)”, Current Opinion in Structural Biology, vol. 23, pp. 748-754. (Year: 2013). [cited by applicant]
Iacuzzi et al., “Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations”, Pharm Res, Springer, Apr. … [cited by applicant]
James, “A Review of Low Angle Fibre Diffraction in the Diagnosis of Disease”, British Journal of Medicine & Medical Research, 3(2): 383-397, Feb. 19, 2013. [cited by applicant]
James, “Fiber diffraction of skin and nails provides an accurate diagnosis of malignancies”, Int. J. Cancer: 125, 133-138, 13 pages, Jul. 2009. [cited by applicant]
Kuwayama et al., “Time-course measurements of drug concentrations in hair and toenails after single administrations of pharmaceutical products”, Drug Testing and Analysis, Jun. 24, 2016, 7 pgs, John Wiley & Sons, Ltd. [cited by applicant]
Lupien et al., “Effects of stress throughout the lifespan on the brain, behaviour and cognition”, Focus on Stress, Jun. 2009, 12 pgs, Macmillan Publishers Limited. [cited by applicant]
Moss et al., Correlation of X-ray diffraction signatures of breast tissue and their histopathological classification, Scientific Reports, Oct. 2017, pp. 1-9. [cited by applicant]
Notice of Allowance and Fees dated Feb. 6, 2023 for U.S. Appl. No. 17/593,846. [cited by applicant]
Notice of Allowance and Fees dated Jul. 19, 2023 for U.S. Appl. No. 17/448,888. [cited by applicant]
Notice of Allowance and Fees dated May 20, 2024 for U.S. Appl. No. 17/448,886. [cited by applicant]
Office Action dated Feb. 26, 2024 for U.S. Appl. No. 17/448,886. [cited by applicant]
Office Action dated Mar. 22, 2023 for U.S. Appl. No. 17/448,888. [cited by applicant]
Oliver et al., Diffraction enhanced imaging utilizing a laser produced x-ray source, Rev. Sci. Instrum. 93, 093502, Sep. 2022, 7 pages. [cited by applicant]
Ong et al., “Optical biosensors—Illuminating the path to personalized drug dosing”, Biosensors and Bioelectronics, May 13, 2021, 21 pgs. [cited by applicant]
Ortiz et al., “Biomarkers of disease in human nails: a comprehensive review”, Critical Reviews in Clinical Laboratory Sciences, Oct. 7, 2021, 18 pgs, Taylor & Francis Group. [cited by applicant]
Park, Hye Lyun, Authorized Officer, Korean Intellectual Property Office, “International Search Report” in connection with related International Application No. PCT/US2021/037238, dated Oct. 5, 2021, 5 pgs. [cited by applicant]
Park, Hye Lyun, Authorized Officer, Korean Intellectual Property Office, “Written Opinion of the InternationalSearching Authority” in connection with related International Application No. PCT/US2021/037238, dated Oct. 5… [cited by applicant]
Rodriguez, Kari, Authorized Officer, Commissioner for Patents, “International Search Report” in connection with related International Application No. PCT/US2021/037224, dated Sep. 29, 2021, 3 pgs. [cited by applicant]
Rodriguez, Kari, Authorized Officer, Commissioner for Patents, “Written Opinion of the International Searching Authority” in connection with related International Application No. PCT/US2021/037224, dated Sep. 29, 2021, … [cited by applicant]
Round et al., A preliminary study of breast cancer diagnosis using laboratory based small angle x-ray scattering, Phys Med Biol. Sep. 2005, 50(17):4159-68. [cited by applicant]
Sidhu et al., Mapping structural changes in breast tissue disease using x-ray scattering, Medical Physics 36, May 2009, pp. 3211-3217. [cited by applicant]
Todd et al., “Survival in dementia and predictors of mortality: a review”, International Journal of Geriatric Psychiatry, Mar. 2013, 16pgs, John Wiley & Sons, Ltd. [cited by applicant]
Visser, “Techniques for Monitoring Drug Efficacy”, Vet Clin North Am Exot Anim Pract., 21(2), May 2018, 287-295, 2018, 7pgs. [cited by applicant]
Wallenburg et al., “Personalised antimicrobial dosing: standing on the shoulders of giants”, International Journal of Antimicrobial Agents, Sep. 2020, 18 pgs. [cited by applicant]
Wiencek, et al., “Rapid Assessment of Drugs of Abuse”, Advances in Clinical Chemistry, Dec. 2016, 33 pgs, Elsevier Inc., Nashville, TN. [cited by applicant]
Yoneyama et al., Fast diffraction-enhanced imaging using continuous sample rotation and analyzer crystal scanning, J Synchrotron Radiat, Mar. 2020, pp. 468-471. [cited by applicant]
Zheng et al., “Recent advances in drug release monitoring”, Nanophotonics, 8(3), Feb. 2009, pp. 391-413. [cited by applicant]
European Search Report dated Dec. 4, 2024 for United Kingdom Patent Application No. 2410187.5. [cited by applicant]
European Search Report dated Dec. 5, 2024 for United Kingdom Patent Application No. 2410185.9. [cited by applicant]
International Search Report and Written Opinion dated Jan. 17, 2025 for PCT Patent Application No. PCT/IB2024/059571. [cited by applicant]
International Search Report and Written Opinion dated Jan. 23, 2025 for PCT Patent Application No. PCT/IB2024/060284. [cited by applicant]
International Search Report and Written Opinion dated Jan. 23, 2025 for PCT Patent Application No. PCT/IB2024/060286. [cited by applicant]
International Search Report and Written Opinion dated Jan. 31, 2025 for PCT Patent Application No. PCT/IB2024/060287. [cited by applicant]
Frolov et al., “Risk stratification personalised model for prediction of life-threatening ventricular tachyarrhythmias in patients with chronic heart failure,” Kardiologia Polska Mar. 2017; 75, 7: 682-688; DOI: 10.5603/… [cited by applicant]
James, “Fiber diffraction of skin and nails provides an accurate diagnosis of malignancies”, Int. J. Cancer: 125, Feb. 2009, pp. 133-138. [cited by applicant]
Lazarev et al., “Human Tissue X-ray Diffraction: Breast, Brain, and Prostate”, Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Cat. No. 00CH37143, vol. 4,… [cited by applicant]
Ortin et al., “Automated real-time method for ventricular heartbeat classification,” Computer Methods and Programs in Biomedicine 169 (2019) 1-8, Nov. 2018, 8 pages. [cited by applicant]
Wang et al., “A High Precision Real-time Premature Ventricular Contraction Assessment Method based on the Complex Feature Set,” Journal of Medical Systems (2020) 44:3, published Nov. 2019, 16 pages. [cited by applicant]
Wu et al., “ECG signal classification with binarized convolutional neural network,” Computers in Biology and Medicine 121, 103800, May 2020, 9 pages. [cited by applicant]
Office Action dated Apr. 8, 2025 for U.S. Appl. No. 18/500,624. [cited by applicant]
Office Action dated Jun. 16, 2025 for U.S. Appl. No. 18/298,190. [cited by applicant]
Office Action dated Jun. 16, 2025 for U.S. Appl. No. 18/298,218. [cited by applicant]
Office Action dated Jul. 25, 2025 for U.S. Appl. No. 18/352,085. [cited by applicant]
Office Action dated Jul. 25, 2025 for U.S. Appl. No. 18/352,094. [cited by applicant]
Notice of Allowance and Fees dated Apr. 14, 2026 for U.S. Appl. No. 18/500,616. [cited by applicant]
Notice of Allowance and Fees dated Mar. 5, 2026 for U.S. Appl. No. 18/827,367. [cited by applicant]
Arboleda et al., “Assessing lesion malignancy by scanning small-angle X-ray scattering breast tissue with microcalcifications”, Physics in Medicine, and Biology, vol. 64, No. 15, pp. 1-9, Dec. 31, 2019. [cited by applicant]
Office Action dated Feb. 9, 2026 for China Patent Application No. 202180042558.4. [cited by applicant]
Sidhu et al., “Classification of breast tissue using a laboratory system for small-angle x-ray scattering (SAXS)”, Physics in Medicine and Biology, vol. 56, pp. 6779-6791. Oct. 5, 2011. [cited by applicant]
Miah et al. (“On-cloud healthcare clinic: an e-health consultancy approach for remote communities in a developing country.” Telematics and Informatics 34.1 (2017): 311-322) (applying e-health solutions) (Year: 2017). [cited by applicant]
Office Action dated Apr. 21, 2026 for U.S. Appl. No. 18/056,219. [cited by applicant]
Office Action dated Apr. 23, 2026 for U.S. Appl. No. 18/827,350. [cited by applicant]
Miah et al. (“On-cloud healthcare clinic: an e-health consultancy approach for remotecountry.” Telematics and Informatics 34.1 (2017): 311-322 (Year: 2017). [cited by applicant]
Notice of Allowance and Fees dated Dec. 2, 2025 for U.S. Appl. No. 18/352,094. [cited by applicant]
Notice of Allowance and Fees dated Oct. 21, 2025 for U.S. Appl. No. 18/298,228. [cited by applicant]
Office Action dated Nov. 26, 2025 for U.S. Appl. No. 18/500,616. [cited by applicant]
Office Action dated Oct. 30, 2025 for U.S. Appl. No. 18/352,085. [cited by applicant]
Office Action dated Oct. 9, 2025 for U.S. Appl. No. 18/298,218. [cited by applicant]
Choi Mina et al: “Feasibility of imaging amyloid in the brain using small-angle x-ray scattering”, Biomedical Physics & Engineering Express, vol. 7, No. 1,Nov. 27, 2020 (Nov. 27, 2020), p. 015008, XP093329220, GB ISSN: … [cited by applicant]
International Search Report and Written Opinion dated Nov. 7, 2025 for PCT Patent Application No. PCT/IB2025/056737. [cited by applicant]